Parth Mehrotra - 08 Jul 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
President and COO
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
08 Jul 2022
Net transactions value
-$410,411
Form type
4
Filing time
11 Jul 2022, 16:26:25 UTC
Previous filing
07 Jul 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock Options Exercise $25,470 +12,735 +13% $2.00* 110,126 08 Jul 2022 Direct
transaction PRVA Common Stock Sale $435,881 -12,735 -12% $34.23 97,391 08 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -12,735 -0.82% $0.000000 1,532,957 08 Jul 2022 Common Stock 12,735 $2.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.74 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,272,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022.